LATAM Genomics Market - Forecast(2020 - 2025)

Report Code: HCR 1321 Report Format: PDF + Excel (Delivery in 48 Hrs)
LATAM Genomics Market Overview
Lower sequencing costs, clear industrial policies, and increased investments in the pharmaceutical sector are the factors driving the LATAM Genomics Market. The LATAM genomics market was valued at $1,364.2m in 2017 and is forecast to reach $2,863.2m by 2025, growing at a CAGR of 9.61% during the forecast period 2017–2025. The market for genomics in Brazil was valued at $614.9m in 2017 and is estimated to increase by 49% by 2025. The growth is majorly attributable to the growth of the healthcare industry and increased demand for personalized medicines in the country.

LATAM Genomics Market Outlook
Genomics is an area that is concerned with the sequencing and analysis of an organism’s genome. It involves the study of genes at a molecular level. Genomics involves the determination of complete DNA sequences and genetic mapping to help understand diseases. It uses a computer aided technology to study the structure and function of the entire genome of an organism. Genomics is related to the mapping and sequencing of genes on a chromosome. The genomics techniques are highly powerful, accurate, efficient, and effective in solving complex genetic problems by analyzing the gene sequence. 

Genomics is widely used in healthcare, agriculture, biotechnology, and diagnostics. In the healthcare sector, genomics is used for the development of vaccines and drugs. It plays an important role in the diagnosis of various genetic disorders and has a broad scope in personalized medicine as it can suggest a medical treatment based on the genetic make-up of a person.  It is also used in synthetic biology and bioengineering. Genomics in agriculture is used for plant breeding and to improve crop yield. The understanding of gene function and the availability of genomic maps along with a better understanding of genetic variation will aid plant breeders to identify the traits and then manipulate those traits to obtain a higher yield.

This report provides an in-depth analysis of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis, and so on, to gauge the impact forces and potential opportunities for the LATAM Genomics market.

LATAM Genomics Market Growth Drivers 
Hospitals and health insurance companies provide genomics testing for patients. Increasing demand for personalized medicines, innovations and developments in technology, and lower cost and time-saving techniques in DNA sequencing are expected to further drive this market. High incidences of lifestyle diseases such as diabetes and cancer coupled with the close attention given by many large and recognized corporates, especially from the healthcare and life sciences industry, are driving the genomics market in Latin America.

LATAM Genomics Market Challenges 
A major challenge for the LATAM genomics market is the non-availability of genomic data. Research organizations and academic centers have to depend on studies based on worldwide populations that have a different genetic makeup compared to the Latin American population. 
The lack developments in biotechnology and information technology in many countries is also of concern. 
The lack of market incentives for the global pharmaceutical industry to pursue genomics-based research. 
While the cost of sequencing a genome has come down rapidly in the past few years, the technology is still expensive to use.

LATAM Genomics Market Research Scope
The base year of the study is 2016, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the LATAM Genomics market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of products and services in the LATAM genomics market, and their specific applications.

LATAM Genomics Market Report: Industry Coverage

Products: Instruments, Arrays, Assays and Reagents and Software

Services: Bioinformatics database, Bio-Informatics Tools, Laboratory Services and Others

Processes: Sampling, Sequencing, Data Analysis, Interpretation and Reporting

Applications: Anthropology, Agriculture, Cytogenetics, Diagnostics, Drug Discovery, Toxicogenomics, Crime Detection

End Users: Hospitals and Clinics, Research Centers, Academic Centers, Government Institutes, Pharmaceutical Companies, Forensic Labs, Others

LATAM Genomics Market Key Players Perspective
Some of the key players mentioned in this report are Illumina, PacBio, Qiagen, and Thermo Fisher Scientific. 

LATAM Genomics Market Trends
  • Focus on developing inexpensive and reliable sequencing methods and equipment to improve data quality and for use in applications such as chromatin accessibility, and whole genome protein binding are driving the LATAM genomics market.
  • Adoption of invasive techniques for sequencing DNA and for knowing the biomarkers of cancers is driving the growth of the LATAM genomics market.
  • Technological advances in genome sequencing, big data and AI promise a new era of personalized medicine. More hospitals, cancer centers, and genomic laboratories are availing services such as clinical informatics, genome classification, and interpretation.  
1. LATAM Genomics Market - Overview
1.1. Definitions and Scope
2. LATAM Genomics Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. LATAM Genomics Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. LATAM Genomics Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. LATAM Genomics Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. LATAM Genomics Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. LATAM Genomics Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. LATAM Genomics Market – By Service (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Bio-Informatics Database
8.3.2. Bio-Informatics Tools
8.3.3. Laboratory Services DNA Sample Sequencing De Novo Sequencing Targeted Re-Sequencing Individual Genome Sequencing SNPS Analysis Molecular Biology Gene Expression Analysis Genotyping Service Biomarker Solutions Others
8.3.4. Others
9. LATAM Genomics Market – By Process (Market Size -$Million / $Billion)
9.1. Introduction
9.2. Sampling
9.3. Sequencing
9.4. Data Analysis
9.5. Interpretation and Reporting
10. LATAM Genomics Market – By Application (Market Size -$Million / $Billion)
10.1. Introduction
10.2. Anthropology
10.3. Agriculture
10.4. Cytogenetics
10.5. Diagnostics
10.5.1. Monogenic (Mendelian) Disorders
10.5.2. Cancer Diagnostics
10.5.3. Others
10.6. Drug Discovery
10.6.1. Oncology
10.6.2. Pharmacology
10.6.3. Rare and Undiagnosed Diseases
10.6.4. Infectious Diseases
10.6.5. Others 
10.7. Toxicogenomics
10.8. Crime Detection
10.9. Others
10. LATAM Genomics – By End User (Market Size -$Million / $Billion)
10.1. Segment type Size and Market Share Analysis 
10.2. Application Revenue and Trends by type of Application
10.3. Application Segment Analysis by Type
10.3.1. Hospitals and Clinics
10.3.2. Research Centres
10.3.3. Academic Centres
10.3.4. Government Institutes 
10.3.5. Pharmaceutical Companies
10.3.6. Forensic Labs
10.3.7. Others
11. LATAM Genomics - By Geography (Market Size -$Million / $Billion)
11.1. LATAM Genomics Market - North America Segment Research
11.2. North America Market Research (Million / $Billion)
11.2.1. Segment type Size and Market Size Analysis 
11.2.2. Revenue and Trends
11.2.3. Application Revenue and Trends by type of Application
11.2.4. Company Revenue and Product Analysis
11.2.5. North America Product type and Application Market Size U.S. Canada Mexico Rest of North America
11.3. LATAM Genomics - South America Segment Research
11.4. South America Market Research (Market Size -$Million / $Billion)
11.4.1. Segment type Size and Market Size Analysis 
11.4.2. Revenue and Trends
11.4.3. Application Revenue and Trends by type of Application
11.4.4. Company Revenue and Product Analysis
11.4.5. South America Product type and Application Market Size Brazil Venezuela Argentina Ecuador Peru Colombia Costa Rica Rest of South America
11.5. LATAM Genomics - Europe Segment Research
11.6. Europe Market Research (Market Size -$Million / $Billion)
11.6.1. Segment type Size and Market Size Analysis 
11.6.2. Revenue and Trends
11.6.3. Application Revenue and Trends by type of Application
11.6.4. Company Revenue and Product Analysis
11.6.5. Europe Segment Product type and Application Market Size U.K Germany Italy France Netherlands Belgium Spain Denmark Rest of Europe
11.7. LATAM Genomics – APAC Segment Research
11.8. APAC Market Research (Market Size -$Million / $Billion)
11.8.1. Segment type Size and Market Size Analysis 
11.8.2. Revenue and Trends
11.8.3. Application Revenue and Trends by type of Application
11.8.4. Company Revenue and Product Analysis
11.8.5. APAC Segment – Product type and Application Market Size China Australia Japan South Korea India Taiwan Malaysia
12. LATAM Genomics Market - Entropy
12.1. New product launches
12.2. M&A's, collaborations, JVs and partnerships
13. LATAM Genomics Market – Industry / Segment Competition landscape Premium
13.1. Market Share Analysis
13.1.1. Market Share by Country- Top companies
13.1.2. Market Share by Region- Top 10 companies
13.1.3. Market Share by type of Application – Top 10 companies
13.1.4. Market Share by type of Product / Product category- Top 10 companies
13.1.5. Market Share at global level- Top 10 companies
13.1.6. Best Practises for companies
14. LATAM Genomics Market – Key Company List by Country Premium
15. LATAM Genomics Market Company Analysis
15.1. Market Share, Company Revenue, Products, M&A, Developments
15.2. Illumina
15.3. PacBio
15.4. Qiagen
15.5. Thermo Fisher Scientific.
15.6. Company 5
15.7. Company 6
15.8. Company 7
15.9. Company 8
15.10. Company 9
15.11. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"
16. LATAM Genomics Market -Appendix
16.1. Abbreviations
16.2. Sources
17. LATAM Genomics Market -Methodology Premium
17.1. Research Methodology
17.1.1. Company Expert Interviews
17.1.2. Industry Databases
17.1.3. Associations
17.1.4. Company News
17.1.5. Company Annual Reports
17.1.6. Application Trends
17.1.7. New Products and Product database
17.1.8. Company Transcripts
17.1.9. R&D Trends
17.1.10. Key Opinion Leaders Interviews
17.1.11. Supply and Demand Trends